Treatment of femoropopliteal arterial lesions with excimer laser atherectomy and drug-coated balloon
Vascular · 2026
DOI: 10.1177/17085381251326331 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Vascular, 2026. Verfasst von Zhijie Liao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Sichuan Mental Health Center, The Third Hospital of Mianyang, P. R. China. Hauptthemen laut MEDLINE: Popliteal Artery, Femoral Artery, Peripheral Arterial Disease, Atherectomy. Die Arbeit nennt 19 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shanghai Science and Technology Committee.
Abstract (Originalsprache)
Objectives
Proximal to mid-term effects of contrast excimer laser atherectomy (ELA) + drug-coated balloon (DCB) versus PTA + drug-coated balloon (DCB) in the treatment of new lesions in the femoral popliteal segment of patients with lower extremity arteriosclerosis and occlusion.
Methods
The clinical data of 105 patients with CT-confirmed femoropopliteal segment lesions (Rutherford grades 3–6) were retrospectively analyzed. According to the computerized randomization method, 58 patients (44 males, mean 72.41 ± 10.58 years) were divided into group A ELA + DCB dilation and 47 patients (35 males, mean 73.83 ± 11.56 years) in group B PTA + DCB dilation. The clinical indexes mainly included the occurrence of Rutherford grade, freedom from target lesion revascularization rate (FTLR), ankle-brachial index (ABI), stage I survival rate, and postoperative complications before, 6 months, and 12 months after surgery and were compared between the two groups.
Results
The treatment success rate was 100% in all patients. The Rutherford grading at 12 months after operation was significantly improved in both groups, but statistical analysis showed that the improvement was more significant in group A (87.93% vs 72.34%, p = 0.043); ABI (0.77 ± 0.22 abc vs 0.65 ± 0.10 abc , p = 0.001); FTLR (93.10% vs 78.72%, p = 0.031), respectively. First-stage patency rate (91.38% vs 74.47%, p < 0.001),; complications, and adverse events were not statistically significant between the two groups ( p > 0.05).
Conclusions
ELA + DCB significantly improved the 1-year freedom from target lesion revascularization rate and stage 1 patency rate with no significant increase in complications or adverse events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sichuan Mental Health Center, The Third Hospital of Mianyang, P. R. China.
- Department of Vascular Surgery, School of Medicine, Shanghai Ninth People's Hospital Affiliated to Shanghai JiaoTong University, Shanghai, P. R. China.
ORCID-Profile: Zhijie Liao
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shanghai Science and Technology Committee
Zitieren
APA
Liao, Z., Qin, J., Liu, L., Zhang, H., Tang, Q., Liu, W., Yin, M., Lu, X., & Zhang, Y. (2026). Treatment of femoropopliteal arterial lesions with excimer laser atherectomy and drug-coated balloon. Vascular. https://doi.org/10.1177/17085381251326331
Vancouver
Liao Z, Qin J, Liu L, Zhang H, Tang Q, Liu W, et al. Treatment of femoropopliteal arterial lesions with excimer laser atherectomy and drug-coated balloon. Vascular. 2026. doi:10.1177/17085381251326331
BibTeX
@article{Liao2026,
author = {Liao, Zhijie and Qin, Jinbao and Liu, Linbo and Zhang, Heng and Tang, Qi and Liu, Wentao and Yin, Minyi and Lu, Xinwu and Zhang, Yi},
title = {Treatment of femoropopliteal arterial lesions with excimer laser atherectomy and drug-coated balloon},
journal = {Vascular},
year = {2026},
doi = {10.1177/17085381251326331}
}
EUVIMED